NCT05027828View on ClinicalTrials.gov

CtDNA as a Novel Biomarker of Treatment Efficacy in Patients With Ovarian Cancer

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

April 30, 2027

Study Completion Date

September 30, 2027

Conditions
High-grade Serous Ovarian CancerCirculating Tumor DNA
Trial Locations (1)

Unknown

RECRUITING

Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai

All Listed Sponsors
lead

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

OTHER